Quantitative pharmacokinetic analysis from DCE-MRI often neglects CA-induced T2*-effect when converting signal intensity (SI) changes in tissue to CA concentration. The acquired signal may thus be significantly affected by T2* signal attenuation, which in turn results in errors in the DCE-derived parameters. This work utilized a dynamic multi-echo acquisition for extrapolation back to TE=0, thus providing both T2*-corrected and uncorrected measurements of DR1, and investigates the how the correction for T2*-attenuation effects may affect the sensitivity for rectal cancer differentiation by DCE-MRI. The T2*-corrected data showed improved differentiation of rectal cancer.
This abstract and the presentation materials are available to members only; a login is required.